Time for a_老虎社区_美港股上老虎

2021-11-12

Time for all the monsters to break into little monsters! 😆 we buy little monsters to grow into bigger monsters

Healthcare giant Johnson & Johnson to split into two companies

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":879205946,"tweetId":"879205946","gmtCreate":1636725626787,"gmtModify":1636725626930,"author":{"id":3582008315299880,"idStr":"3582008315299880","authorId":3582008315299880,"authorIdStr":"3582008315299880","name":"KLCC","avatar":"https://static.tigerbbs.com/08be1d09de6993c135144551b2568831","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":4,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":32,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body><p>Time for all the monsters to break into little monsters! 😆 we buy little monsters to grow into bigger monsters&nbsp;</p></body></html>","htmlText":"<html><head></head><body><p>Time for all the monsters to break into little monsters! 😆 we buy little monsters to grow into bigger monsters&nbsp;</p></body></html>","text":"Time for all the monsters to break into little monsters! 😆 we buy little monsters to grow into bigger monsters","highlighted":1,"essential":1,"paper":1,"likeSize":9,"commentSize":5,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/879205946","repostId":2182236092,"repostType":4,"repost":{"id":"2182236092","kind":"news","pubTimestamp":1636725153,"share":"https://www.laohu8.com/m/news/2182236092?lang=&edition=full","pubTime":"2021-11-12 21:52","market":"us","language":"en","title":"Healthcare giant Johnson & Johnson to split into two companies","url":"https://stock-news.laohu8.com/highlight/detail?id=2182236092","media":"Reuters","summary":"(Reuters) -Johnson & Johnson said on Friday it is planning to break up into two companies, splitting","content":"<p>(Reuters) -Johnson &amp; Johnson said on Friday it is planning to break up into two companies, splitting off its consumer health division that sells Band-Aids and Baby Powder from its large pharmaceuticals unit.</p>\n<p>The healthcare conglomerate will separate its consumer health business into a new publicly traded company. Rival Pfizer Inc had in 2019 combined its consumer health unit with GlaxoSmithKline plc in a joint venture.</p>\n<p>Johnson &amp; Johnson said it is aiming to complete the planned separation in 18 to 24 months, sending its shares up 5% before the bell.</p>\n<p>The company will retain its pharmaceuticals and medical device units, which sells drugs such as cancer treatment Darzalex. The units are expected to generate revenue of roughly $77 billion in 2021.</p>\n<p>\"The new Johnson &amp; Johnson and the New Consumer Health Company would each be able to more effectively allocate resources to deliver for patients and consumers, drive growth and unlock significant value,\" said Joaquin Duato, who is expected to become J&amp;J's chief executive officer in January.</p>\n<p>The planned split comes days after U.S. industrial conglomerate General Electric Co said it would separate into three public companies to simplify its business and pare down debt.</p>\n<p>On Friday, Japan's Toshiba Corp outlined plans on Friday to split into three independent companies.</p>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Healthcare giant Johnson & Johnson to split into two companies</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHealthcare giant Johnson & Johnson to split into two companies\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-12 21:52 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/johnson-johnson-plans-split-two-112833577.html><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>(Reuters) -Johnson & Johnson said on Friday it is planning to break up into two companies, splitting off its consumer health division that sells Band-Aids and Baby Powder from its large ...</p>\n\n<a href=\"https://finance.yahoo.com/news/johnson-johnson-plans-split-two-112833577.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"JNJ":"强生"},"source_url":"https://finance.yahoo.com/news/johnson-johnson-plans-split-two-112833577.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2182236092","content_text":"(Reuters) -Johnson & Johnson said on Friday it is planning to break up into two companies, splitting off its consumer health division that sells Band-Aids and Baby Powder from its large pharmaceuticals unit.\nThe healthcare conglomerate will separate its consumer health business into a new publicly traded company. Rival Pfizer Inc had in 2019 combined its consumer health unit with GlaxoSmithKline plc in a joint venture.\nJohnson & Johnson said it is aiming to complete the planned separation in 18 to 24 months, sending its shares up 5% before the bell.\nThe company will retain its pharmaceuticals and medical device units, which sells drugs such as cancer treatment Darzalex. The units are expected to generate revenue of roughly $77 billion in 2021.\n\"The new Johnson & Johnson and the New Consumer Health Company would each be able to more effectively allocate resources to deliver for patients and consumers, drive growth and unlock significant value,\" said Joaquin Duato, who is expected to become J&J's chief executive officer in January.\nThe planned split comes days after U.S. industrial conglomerate General Electric Co said it would separate into three public companies to simplify its business and pare down debt.\nOn Friday, Japan's Toshiba Corp outlined plans on Friday to split into three independent companies.","news_type":1},"isVote":1,"tweetType":1,"viewCount":304,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":92,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/879205946"}